Massive biobank launches to unlock secrets of MS and related disorders

NCT ID NCT00445367

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is creating a large, long-term collection of blood samples and health information from over 3,200 people with multiple sclerosis and related demyelinating diseases, as well as healthy volunteers. The goal is to provide scientists with a shared resource to better understand what causes these diseases, identify different subtypes, and discover biomarkers. Participants provide blood samples and medical data, but this study does not test any new treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE DISSEMINATED ENCEPHALOMYELITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Barrow Neurological Institute

    Phoenix, Arizona, 85013, United States

  • Beth Israel Deaconess

    Boston, Massachusetts, 02215, United States

  • Johns Hopkins

    Baltimore, Maryland, 21287, United States

  • Multiple Sclerosis Research Center of New York

    New York, New York, 10019, United States

  • Shepherd Center

    Atlanta, Georgia, 30309, United States

  • Stanford University

    Stanford, California, 94305, United States

  • The Ohio State University

    Columbus, Ohio, 43210, United States

  • The Rocky Mountain MS Center at Anschutz Medical Campus at UC Denver

    Aurora, Colorado, 80045, United States

  • University of Massachusetts Medical School

    Worcester, Massachusetts, 01605, United States

  • University of Texas Southwestern Medical Center at Dallas

    Dallas, Texas, 76051, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.